相关实验视频

Updated: Jun 12, 2025

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

在老鼠中,埃斯基塔洛普拉姆可以逆转由皮质激素诱导的同时发生的抑郁症和过度活跃的膀

Gongyue Liu¹, Zhonghan Zhou¹, Xin Liu²

¹School of Rehabilitation of Capital Medical University, Department of Urology, China Rehabilitation Research Center, Beijing, China; China Rehabilitation Science Institute, Beijing, China; Urological and Pelvic Floor Rehabilitation Center, Beijing Bo'ai Hospital, Beijing, China.

European journal of pharmacology

|June 6, 2025

概括

埃斯基塔洛普拉姆有效治疗老鼠的抑郁症和过度活动的膀 (OAB). 这种选择性血清素再吸收抑制剂 (SSRI) 与其他测试药物不同,改善了情绪和膀功能.

科学领域:

神经科学和药理学神经科学和药理学
泌尿病学和行为科学泌尿病学和行为科学

背景情况:

同时存在的抑郁症和过度活跃的膀 (OAB) 构成了复杂的临床挑战.
选择性血清素再吸收抑制剂 (SSRI) 主要用于抑郁症,但它们对OAB的影响不太清楚.
在老鼠中使用皮质 (CORT) 是一种有效的模式,可以诱导抑郁症状和膀功能障碍.

研究的目的:

评估ESCITALOPRAM (一种SSRI) 的疗效,在表现出抑郁症和OAB的老鼠模型中.
为了比较埃斯基塔洛普拉姆与已确定的OAB药物 (索利费纳辛,米拉贝格朗) 的作用,以及盐水对照.

主要方法:

在30只雌性Sprague-Dawley大鼠中,使用皮质 (CORT) 注射诱导了抑郁和OAB.
鼠被用埃斯基塔洛普拉姆,索利费纳辛,米拉贝格朗或盐水治疗了14天.
行为测试 (新型物体识别任务,尾部悬浮测试) 和囊泡测量分析评估了抑郁症状和膀功能.

主要成果:

埃斯基塔洛普拉姆显著改善了抑郁症状,行为测试的表现有所改善.
囊管测量显示,埃斯基塔洛普拉姆恢复了膀容量,收缩间隔和膀符合控制水平.
索利菲纳和米拉贝格朗在评估的抑郁或膀参数中没有显著改善.

结论:

在这个临床前模型中,埃斯基塔洛普拉姆显示出双重治疗效果,缓解抑郁症状和过度活跃的膀功能障碍.
这些发现表明,埃斯基塔洛普拉姆是患有并发性抑郁症和OAB的患者的潜在治疗药物.
需要进一步的临床研究来确认人类患者的长期疗效和安全性.

关键词:

焦虑焦虑是一种焦虑.抑郁症抑郁症抑郁症埃斯基塔洛普拉姆 (escitalopram) 是一种药物.过度活动的膀.选择性血清素再吸收抑制剂选择性血清素再吸收抑制剂

更多相关视频

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

Published on: January 9, 2015

相关概念视频

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...